First Trust Capital Management L.P. Acquires New Position in BioLife Solutions, Inc. $BLFS

First Trust Capital Management L.P. acquired a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,425,085 shares of the medical equipment provider’s stock, valued at approximately $55,365,000. BioLife Solutions accounts for about 2.7% of First Trust Capital Management L.P.’s holdings, making the stock its 8th biggest position.

Other hedge funds also recently modified their holdings of the company. Nisa Investment Advisors LLC lifted its position in shares of BioLife Solutions by 13.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,209 shares of the medical equipment provider’s stock valued at $86,000 after acquiring an additional 260 shares during the period. Yousif Capital Management LLC grew its holdings in BioLife Solutions by 4.9% in the third quarter. Yousif Capital Management LLC now owns 11,097 shares of the medical equipment provider’s stock worth $431,000 after purchasing an additional 520 shares during the period. GAMMA Investing LLC grew its holdings in BioLife Solutions by 7.2% in the third quarter. GAMMA Investing LLC now owns 9,647 shares of the medical equipment provider’s stock worth $375,000 after purchasing an additional 651 shares during the period. Oregon Public Employees Retirement Fund increased its stake in BioLife Solutions by 7.8% in the third quarter. Oregon Public Employees Retirement Fund now owns 9,685 shares of the medical equipment provider’s stock valued at $376,000 after purchasing an additional 700 shares in the last quarter. Finally, Cannell & Spears LLC increased its stake in BioLife Solutions by 3.2% in the first quarter. Cannell & Spears LLC now owns 26,261 shares of the medical equipment provider’s stock valued at $493,000 after purchasing an additional 825 shares in the last quarter. Institutional investors own 93.24% of the company’s stock.

BioLife Solutions Stock Performance

Shares of BioLife Solutions stock opened at $38.61 on Friday. The company has a market capitalization of $1.89 billion, a P/E ratio of 33.28 and a beta of 1.82. The stock has a fifty day simple moving average of $37.87 and a 200 day simple moving average of $28.57. BioLife Solutions, Inc. has a 12-month low of $17.86 and a 12-month high of $39.76.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on BLFS shares. Craig Hallum lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating and set a $31.00 price objective on the stock. in a report on Wednesday, July 22nd. Maxim Group downgraded BioLife Solutions from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Zacks Research lowered BioLife Solutions from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 21st. Weiss Ratings upgraded BioLife Solutions from a “sell (d-)” rating to a “hold (c)” rating in a report on Tuesday, September 22nd. Finally, TD Cowen lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating and decreased their price target for the company from $33.00 to $31.00 in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $31.38.

BioLife Solutions Profile

BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials. The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.